Integrating Biomarkers & Genomics to Decision-Making Protocol on HFpEF Treatments

Time: 11:10 am
day: Day One


  • Introducing one of the largest genome wide studies for heart failure published
  • Leveraging the use of genomics and heart failure in decision making for both HFpEF and HFrEF in the area of cell and gene therapy
  • Uncovering tissue targeting and tissue specificity of these emerging therapies for effective early treatment and prevention